BeStock  
Stocks › Biotechnology › INSM

Insmed INSM

US equityMarket cap rank #631Biotechnology
$141.33 −$3.13 (-2.17%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $142.81 +1.05%
Open$143.27
Prev close$144.46
Day range$140.99 – $150.00
Volume6.22M
Market cap$31.01B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts16
Average target$191.07+35.2% vs. price
  • Buy 94%
  • Hold 6%
Low $158.00Now $141.33Avg $191.07High $220.00

Recent rating changes

The last 20 actions on file set price targets from $154.00 to $220.00, averaging $192.05.

DateFirmRatingTarget
20 Nov 2026 BofA Securities BUY $205.00
19 Nov 2026 Mizuho Securities BUY $158.00
19 Nov 2026 Raymond James BUY –
19 Nov 2026 BofA Securities BUY $205.00
19 Nov 2026 Guggenheim BUY $201.00
17 Nov 2026 RBC Capital BUY $195.00
13 Nov 2026 Morgan Stanley BUY $213.00
5 Nov 2026 Evercore BUY $170.00
4 Nov 2026 H.C. Wainwright BUY $220.00
3 Nov 2026 Mizuho Securities BUY $158.00
2 Nov 2026 BMO Capital BUY $192.00
2 Nov 2026 Barclays BUY $207.00
1 Nov 2026 Guggenheim BUY $201.00
30 Oct 2026 UBS BUY $172.00
30 Oct 2026 Morgan Stanley BUY $213.00
30 Oct 2026 BMO Capital BUY $192.00
30 Oct 2026 Goldman Sachs BUY $194.00
29 Oct 2026 Mizuho Securities BUY $154.00
29 Oct 2026 Roth MKM BUY $204.00
29 Oct 2026 RBC Capital BUY $195.00

Discussion

No comments yet — be the first to weigh in on INSM.

Sign in to join the discussion.

Scroll to Top